Long-Term Outcomes of Coronary Artery Aneurysms in Children With Kawasaki Disease: A Systematic Review

Shoaib Syed Mohammed Shafy1, Karla Andrea Calderón Salavarria2, Sara Saleh3

  • 1Critical Care Medicine, Yenepoya Medical College and Research Center, Mangalore, IND.

Cureus
|November 14, 2025
PubMed

Insights

Kawasaki disease (KD) can cause coronary artery aneurysms (CAAs) in children. Early IVIG treatment improves CAA regression, while giant aneurysms require aggressive management and surveillance.

Area of Science:

  • Pediatric Cardiology
  • Rheumatology
  • Vascular Biology

Background:

  • Kawasaki disease (KD) is a leading cause of acquired pediatric heart disease.
  • Coronary artery aneurysms (CAAs) are the most serious complication of KD, leading to long-term morbidity and mortality.
  • Understanding long-term CAA outcomes is crucial for patient management.

Purpose of the Study:

  • To systematically review the long-term outcomes of CAAs in children with KD.
  • To analyze CAA regression rates, associated complications, and the impact of medical and surgical interventions.
  • To provide evidence for optimizing the long-term care and surveillance of KD patients with CAAs.

Main Methods:

  • Systematic review of 21 studies.
  • Inclusion of 10,922 patients diagnosed with KD and CAAs.
  • Analysis of data on CAA incidence, regression, complications, and treatment outcomes.

Main Results:

  • CAA incidence in KD ranged from 3% to 27%, predominantly in infants under 6 months.
  • Most small and moderate CAAs (>80%) regressed, unlike giant aneurysms.
  • Early intravenous immunoglobulin (IVIG) treatment improved regression rates; left anterior descending artery aneurysms showed less regression.
  • Complications included thrombosis, myocardial infarction, major adverse cardiac events, and cardiac death.
  • Coronary artery bypass grafting was the primary surgical intervention.

Conclusions:

  • Early and aggressive management of KD with IVIG, potentially escalated with steroids or biologics, is preferred.
  • Surgical intervention is indicated for giant or persistent CAAs.
  • Timely diagnosis, risk stratification, and standardized guidelines are essential for optimal long-term care and surveillance of KD patients with CAAs.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
249
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
258
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
336
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
207
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
383